Paul Richard Rhomberg (Paul R Rhomberg)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Candida Albicans

Genetic Diversity

Coronavirus Disease

Top Venues

Journal of clinical microbiology

Antimicrobial agents and chemotherapy

The Pediatric infectious disease journal

Medical mycology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael A Pfaller, Cecilia Godoy Carvalhaes, Sean DeVries, Paul Richard Rhomberg, Mariana Castanheira
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections. Medical mycology 60 (5) (2022)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Paul Richard Rhomberg, Mariana Castanheira, Sean DeVries, Rodrigo Elisandro Mendes
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019). The Pediatric infectious disease journal 41 (9) (2022)
Cecilia Godoy Carvalhaes, Abby L Klauer, Paul Richard Rhomberg, Michael A Pfaller, Mariana Castanheira
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020). Journal of clinical microbiology 60 (4) (2022)
Rodrigo Elisandro Mendes, Paul Richard Rhomberg, Troy Lister, Nicole Cotroneo, Thomas R Parr, Mariana Castanheira
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae, Including Molecularly Characterized Strains. Antimicrobial agents and chemotherapy 65 (1) (2020)